Chemistry: physical processes – Physical processes – Crystallization
Patent
1978-11-06
1980-05-13
Marantz, Sidney
Chemistry: physical processes
Physical processes
Crystallization
424 12, G01N 3316
Patent
active
042026652
ABSTRACT:
The reversed passive hemagglutination test (RPHA) for the detection of hepatitis B surface antigen (HB.sub.s Ag) is improved by the recognition that the speed of movement towards the periphery of a centrifugal field by immunologically aggregated solid phase support particles, increases proportionally with the amount of antigen present. It is further recognized that this dynamic study can be performed objectively and in an automated fashion by equipment such as the miniature centrifugal fast analyzer. The test performed in this manner and known as "reversed passive hemagglutination by minature centrifugal fast analysis" (RPHA/MCFA) is highly specific and eliminates the need for subsequent confirmational studies. Preliminary studies confirm a sensitivity comparable to other third generation tests.
REFERENCES:
patent: 3829223 (1974-08-01), Hamel
patent: 3992517 (1976-11-01), Lowke
patent: 4080264 (1978-03-01), Cohen
patent: 4113712 (1978-09-01), Fundroshi
patent: 4130634 (1978-12-01), Molinaro
patent: 4133873 (1979-01-01), Noller
patent: 4136161 (1979-01-01), Falkowski
Feng Chi Shun
Karmen Arthur
Wenz Barry
Albert Einstein College of Medicine of Yeshiva University a Divi
Feldman Marvin
Feldman Stephen E.
Marantz Sidney
LandOfFree
Detection of hepatitis B surface antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of hepatitis B surface antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of hepatitis B surface antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-928073